Immunic, Inc. (IMUX)
0.6873
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
0.6954
+0.01
(+1.18%)
After-Hours: 20:00
Immunic EPS Diluted (Quarterly): -0.1319 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aardvark Therapeutics, Inc. | -0.7503 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.58M |
| Total Expenses (Quarterly) | 25.58M |
| Enterprise Value | 48.33M |
| Earnings Yield | -125.9% |
| Normalized Earnings Yield | -125.93 |